The story of Viagra, formerly marketed by copyright, presents a intricate case study for backers considering the pharmaceutical sector. While its early success and impact of vast in earnings , the patent expiration has opened the door for alternative medications, substantially diminishing profit opportunities. This shift raises questions about the